Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
Human cells are relatively resistant to lysis by the homologous complement system. Here we describe the mechanism of action of a recently discovered and widely distributed 18,000-20,000 molecular weight (MW) membrane glycoprotein (CD59), which appears to act as a major protective element against com...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1990
|
| _version_ | 1797102234389970944 |
|---|---|
| author | Meri, S Morgan, B Davies, A Daniels, R Olavesen, MG Waldmann, H Lachmann, P |
| author_facet | Meri, S Morgan, B Davies, A Daniels, R Olavesen, MG Waldmann, H Lachmann, P |
| author_sort | Meri, S |
| collection | OXFORD |
| description | Human cells are relatively resistant to lysis by the homologous complement system. Here we describe the mechanism of action of a recently discovered and widely distributed 18,000-20,000 molecular weight (MW) membrane glycoprotein (CD59), which appears to act as a major protective element against complement-mediated lysis (hence called protectin). When incorporated into heterologous erythrocyte membranes, protectin efficiently prevented cell lysis by human serum. Neutralization with antibody of the naturally occurring protectin on human erythrocytes or on nucleated K562 cells increased their susceptibility to lysis by homologous complement. During complement activation, protectin became incorporated into the membrane attack complex (MAC). By interacting with newly exposed regions in the C5b-8 complex and in aggregating C9 it limited the number of C9 molecules associating with the C5b-8 complex to a C8:C9 ratio of 1:1.5 instead of a normal average of 1:3.5. The results demonstrate directly that protectin is a powerful inhibitor of complement cytolysis and acts by inhibiting the C5b-8 catalysed insertion of C9 into the lipid bilayer. |
| first_indexed | 2024-03-07T06:03:05Z |
| format | Journal article |
| id | oxford-uuid:ece4cd87-66d0-4d4c-9c3a-015e57682c97 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:03:05Z |
| publishDate | 1990 |
| record_format | dspace |
| spelling | oxford-uuid:ece4cd87-66d0-4d4c-9c3a-015e57682c972022-03-27T11:20:49ZHuman protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ece4cd87-66d0-4d4c-9c3a-015e57682c97EnglishSymplectic Elements at Oxford1990Meri, SMorgan, BDavies, ADaniels, ROlavesen, MGWaldmann, HLachmann, PHuman cells are relatively resistant to lysis by the homologous complement system. Here we describe the mechanism of action of a recently discovered and widely distributed 18,000-20,000 molecular weight (MW) membrane glycoprotein (CD59), which appears to act as a major protective element against complement-mediated lysis (hence called protectin). When incorporated into heterologous erythrocyte membranes, protectin efficiently prevented cell lysis by human serum. Neutralization with antibody of the naturally occurring protectin on human erythrocytes or on nucleated K562 cells increased their susceptibility to lysis by homologous complement. During complement activation, protectin became incorporated into the membrane attack complex (MAC). By interacting with newly exposed regions in the C5b-8 complex and in aggregating C9 it limited the number of C9 molecules associating with the C5b-8 complex to a C8:C9 ratio of 1:1.5 instead of a normal average of 1:3.5. The results demonstrate directly that protectin is a powerful inhibitor of complement cytolysis and acts by inhibiting the C5b-8 catalysed insertion of C9 into the lipid bilayer. |
| spellingShingle | Meri, S Morgan, B Davies, A Daniels, R Olavesen, MG Waldmann, H Lachmann, P Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title_full | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title_fullStr | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title_full_unstemmed | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title_short | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. |
| title_sort | human protectin cd59 an 18 000 20 000 mw complement lysis restricting factor inhibits c5b 8 catalysed insertion of c9 into lipid bilayers |
| work_keys_str_mv | AT meris humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT morganb humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT daviesa humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT danielsr humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT olavesenmg humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT waldmannh humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers AT lachmannp humanprotectincd59an1800020000mwcomplementlysisrestrictingfactorinhibitsc5b8catalysedinsertionofc9intolipidbilayers |